天堂国产午夜亚洲专区-少妇人妻综合久久蜜臀-国产成人户外露出视频在线-国产91传媒一区二区三区

輸注人PBMC建立“人—鼠”異種移植物抗宿主病模型

發(fā)布時(shí)間:2018-04-01 21:34

  本文選題:器官移植 切入點(diǎn):異種移植 出處:《華中科技大學(xué)》2011年碩士論文


【摘要】:在人體內(nèi)的實(shí)驗(yàn)由于道德、倫理、法律等諸方面的制約而受到嚴(yán)格限制,涉及人體細(xì)胞的研究一般只能進(jìn)行體外實(shí)驗(yàn),而體外實(shí)驗(yàn)的結(jié)果往往與體內(nèi)情況存在一定的差別;“人-鼠”模型的建立,為在體內(nèi)研究提供了可能。然而目前對(duì)人-鼠模型的報(bào)道也較多,但行之有效且較穩(wěn)定的方法報(bào)道甚少?晒┙梃b的異種移植物抗宿主病模型(graft-versus-host disease,GVHD)以“人-鼠”模型應(yīng)用最廣泛,但建立的方法也有較多的報(bào)道。本研究主要探討選擇合適小鼠品系,優(yōu)化相關(guān)實(shí)驗(yàn)條件,建立穩(wěn)定的“人-鼠”異種移植物抗宿主病(X-GVHD)模型,為研究誘導(dǎo)人T細(xì)胞耐受提供動(dòng)物模型。主要內(nèi)容與結(jié)果如下: 本研究選取了裸鼠、NOD/SCID經(jīng)亞致死劑量γ射線全身照射后,腹腔輸注健康人外周血單核細(xì)胞(PBMC)建立異種急性X-GVHD模型。通過(guò)檢測(cè)人T細(xì)胞在尾靜脈血、組織、器官中的浸潤(rùn)情況等指標(biāo)(采用流式細(xì)胞術(shù)和免疫組化技術(shù)),比較兩種模型鼠中人免疫細(xì)胞的浸潤(rùn)率,各組生存時(shí)間,從而確定建立X-GVHD模型的合適小鼠品系,并摸索人PBMC的輸注途徑和合適細(xì)胞量,以及觀察免疫細(xì)胞表型變化與功能的最佳時(shí)間窗口。 結(jié)果顯示,NOD/SCID鼠更適合誘導(dǎo)“人鼠”X-GVHD模型的小鼠;腹腔輸注途徑和尾靜脈輸注途徑對(duì)建立“人鼠”X-GVHD模型無(wú)明顯差異;腹腔輸注5×107以上人PBMC可以成功建立“人鼠”X-GVHD模型。在采用優(yōu)化后的實(shí)驗(yàn)條件建立模型中,監(jiān)測(cè)人T細(xì)胞表型動(dòng)態(tài)變化與功能的最佳時(shí)間窗口為7-11天;模型鼠的平均生存時(shí)間為14.16±1.77天。 本研究的創(chuàng)新點(diǎn)和意義: 本研究使用不同的小鼠建立模型,經(jīng)檢測(cè)后,建立了“人-NOD/SCID異種急性移植物抗宿主病模型”,進(jìn)一步優(yōu)化各項(xiàng)條件,建立了穩(wěn)定的“人-鼠”X-GVHD模型,該模型為誘導(dǎo)人T細(xì)胞耐受的研究提供了實(shí)驗(yàn)依據(jù)。同時(shí)該模型可以用于體內(nèi)藥敏實(shí)驗(yàn)研究,預(yù)測(cè)指導(dǎo)臨床治療方案的選擇和設(shè)計(jì),以及探索放療、內(nèi)分泌治療、免疫治療、基因治療及分子靶向治療等新型的治療手段。
[Abstract]:Experiments in the human body are severely restricted by moral, ethical, legal and other constraints. Studies involving human cells are generally confined to in vitro experiments. However, the results of in vitro experiments are often different from those in vivo, and the establishment of the "human-mouse" model makes it possible to study in vivo. However, there are many reports on the human-mouse model at present. However, there are few reports of effective and stable methods. Graft-versus-host disease (GVHD), a model of xenograft-versus-host disease (GVHD), is the most widely used in the "human-mouse" model. However, there are many reports on the established methods. In this study, the suitable strain of mouse was selected, the experimental conditions were optimized, and a stable "human-mouse" xenograft versus host disease X-GVHD model was established. To provide an animal model for the study of inducing human T cell tolerance. The main contents and results are as follows:. In this study, a xenogeneic acute X-GVHD model was established by intraperitoneal infusion of nod / SCID into healthy human peripheral blood monocytes after whole-body irradiation with sublethal dose 緯 -ray. Human T cells were detected in caudal vein blood and tissue. The infiltration rate of human immune cells and survival time of each group were compared by flow cytometry and immunohistochemical technique, so as to determine the appropriate strain of X-GVHD model. The optimal time window for observation of phenotypic changes and function of immune cells was found. The results showed that Nod / SCID mice were more suitable for inducing "human mouse" X-GVHD model, and there was no significant difference between intraperitoneal infusion pathway and caudal vein infusion pathway in the establishment of "human mouse" X-GVHD model. The "human mouse" X-GVHD model could be successfully established by intraperitoneal infusion of human PBMC. The optimal time window for monitoring the phenotypic changes and functions of human T cells was 7-11 days. The average survival time of the model rats was 14.16 鹵1.77 days. The innovation and significance of this study:. In this study, different mouse models were used to establish a human NOD / SCID xenograft-versus-host disease model. The conditions were optimized and a stable human-mouse X-GVHD model was established. The model provides experimental basis for the study of inducing human T cell tolerance. It can also be used to study drug sensitivity in vivo, predict and guide the selection and design of clinical treatment schemes, and explore radiotherapy, endocrine therapy and immunotherapy. Gene therapy and molecular targeting therapy.
【學(xué)位授予單位】:華中科技大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2011
【分類號(hào)】:R392

【參考文獻(xiàn)】

相關(guān)期刊論文 前3條

1 周雪瑞;黃選東;;免疫缺陷動(dòng)物裸鼠[J];生物學(xué)教學(xué);2007年03期

2 葉慶,王志華,鎮(zhèn)鴻燕,王碩,朱慧芬,沈關(guān)心;人-鼠異基因移植物抗宿主動(dòng)物模型的建立與檢測(cè)[J];華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2004年06期

3 王坤杰,李幼平,楊宇如;異種移植中的移植物抗宿主病[J];中國(guó)修復(fù)重建外科雜志;2000年03期

,

本文編號(hào):1697387

資料下載
論文發(fā)表

本文鏈接:http://sikaile.net/xiyixuelunwen/1697387.html


Copyright(c)文論論文網(wǎng)All Rights Reserved | 網(wǎng)站地圖 |

版權(quán)申明:資料由用戶ed5cc***提供,本站僅收錄摘要或目錄,作者需要?jiǎng)h除請(qǐng)E-mail郵箱bigeng88@qq.com